OBJECTIVE Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are neurodegenerative diseases that can be difficult to distinguish clinically. The objective of the current study was to use surface-based analysis techniques to assess cortical thickness, surface area and grey matter volume to identify unique morphological patterns of cortical atrophy in PD, MSA and PSP and to relate these patterns of change to disease duration and clinical features. METHODS High resolution 3D T1-weighted MRI volumes were acquired from 14 PD patients, 18 MSA, 14 PSP and 19 healthy control participants. Cortical thickness, surface area and volume analyses were carried out using the automated surface-based ana...
none13noObjectives: To evaluate white matter and cortical changes in patients with parkinsonisms and...
Objectives: To evaluate the magnetic resonance imaging (MRI)-derived parameters in differentiation o...
WOS: 000459561000002PubMed: 30373485Objectives: To evaluate the magnetic resonance imaging (MRI)-der...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Objective: Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Pals...
International audienceWith the ability to study brain anatomy in vivo using magnetic resonance imagi...
Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple ...
Background: The absence of markers for ante-mortem diagnosis of progressive supranuclear palsy (PSP)...
Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple ...
Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple ...
OBJECTIVES: Parkinson’s disease (PD) and the parkinsonian variant of multiple system atrophy (MSA-P)...
Background: The regional distribution of the widespread cerebral morphological alterations in progre...
Although often clinically indistinguishable in the early stages, Parkinson’s disease (PD), Multiple ...
Background: Imaging studies have revealed cortical thinning and subcortical atrophy occurring in Par...
none13noObjectives: To evaluate white matter and cortical changes in patients with parkinsonisms and...
Objectives: To evaluate the magnetic resonance imaging (MRI)-derived parameters in differentiation o...
WOS: 000459561000002PubMed: 30373485Objectives: To evaluate the magnetic resonance imaging (MRI)-der...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Objective: Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Pals...
International audienceWith the ability to study brain anatomy in vivo using magnetic resonance imagi...
Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple ...
Background: The absence of markers for ante-mortem diagnosis of progressive supranuclear palsy (PSP)...
Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple ...
Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple ...
OBJECTIVES: Parkinson’s disease (PD) and the parkinsonian variant of multiple system atrophy (MSA-P)...
Background: The regional distribution of the widespread cerebral morphological alterations in progre...
Although often clinically indistinguishable in the early stages, Parkinson’s disease (PD), Multiple ...
Background: Imaging studies have revealed cortical thinning and subcortical atrophy occurring in Par...
none13noObjectives: To evaluate white matter and cortical changes in patients with parkinsonisms and...
Objectives: To evaluate the magnetic resonance imaging (MRI)-derived parameters in differentiation o...
WOS: 000459561000002PubMed: 30373485Objectives: To evaluate the magnetic resonance imaging (MRI)-der...